Inventor · disambiguated record
Andrew Craig
Also filed as: CRAIG ANDREW · CRAIG ANDREW S · CRAIG ANDREW SIMON
12 granted patents·31 pending applications·135 citations·filing 1999–2022
91Inventor score
Files withSMITHKLINE BEECHAM PLC17SMITHKLINE BEECHAM CORP4CRAIG ANDREW SIMON2GLAXO GROUP LTD2UNIV KINGSTON2
Top patents by PatentIndex Score
43 records- 0189US6777400B2Anti-inflammatory androstane derivative compositionsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 17, 2004·40 cites·16 claims
- 0283US6777399B2Anti-inflammatory androstane derivative compositionsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 17, 2004·16 cites·30 claims
- 0380US6699882B2Paroxetine compositionsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Mar 2, 2004·10 cites·1 claims
- 0478US8796269B2Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the sameCRAIG ANDREW SIMON·Filed 2010·Granted Aug 5, 2014·11 cites·9 claims
- 0578US6858593B2Anti-inflammatory androstane derivative compositionsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Feb 22, 2005·15 cites·12 claims
- 0677US7592329B2Crystalline complexes of fluticasone-2-furoateGLAXO GROUP LTD·Filed 2003·Granted Sep 22, 2009·10 cites·10 claims
- 0775US11369594B2Cytotoxic actin-targeting compoundsUNIV KINGSTON·Filed 2018·Granted Jun 28, 2022·1 cites·21 claims
- 0874US6063927AParoxetine derivativesSMITHKLINE BEECHAM PLC·Filed 1999·Granted May 16, 2000·26 cites·4 claims
- 0973US7074811B2Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dioneSMITHKLINE BEECHAM PLC·Filed 2001·Granted Jul 11, 2006·6 cites·17 claims
- 1068US12239639B2Cytotoxic actin-targeting compoundsUNIV KINGSTON·Filed 2022·Granted Mar 4, 2025·0 cites·15 claims
- 1159US2007185167A1Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dioneSMITHKLINE BEECHAM PLC·Filed 2007·Application pending·0 cites
- 1257US2004247667A1Novel compoundSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 1356US2007191435A1Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dioneSMITHKLINE BEECHAM PLC·Filed 2007·Application pending·0 cites
- 1455US2006004058A1Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl) amino) ethoxy!benzyl!thiazolidine -2, 4-dioneSMITHKLINE BEECHAM PLC·Filed 2005·Application pending·0 cites
- 1555US2005277679A9Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dioneSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 1654US2003203937A1Novel compoundSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 1753US2004224932A1Novel anti-inflammatory androstane derivative compositionsFiled 2004·Application pending·0 cites
- 1852US2005282867A1Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dioneSMITHKLINE BEECHAM PLC·Filed 2005·Application pending·0 cites
- 1950US2002193406A1Novel compoundSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 2049US2011245496A1Quinazoline Salt CompoundsCRAIG ANDREW SIMON·Filed 2008·Application pending·0 cites
- 2149US2004220156A1Novel anti-inflammatory androstane derivative compositionsFiled 2004·Application pending·0 cites
- 2249US2001023252A1Novel compoundSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2349US2005267162A1Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dioneSMITHKLINE BEECHAM PLC·Filed 2005·Application pending·0 cites
- 2449US2002035130A1Novel compoundSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2548US7291740B25-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate saltSMITHKLINE BEECHAM PLC·Filed 2005·Granted Nov 6, 2007·0 cites·3 claims
- 2648US2004014752A1Sodium salts of 5-[4-]2-(n-methyl-N-(2-pyridyl) ethoxy]benzyl]thiazolidine-2,4-dioneFiled 2001·Application pending·0 cites
- 2748US2001023253A1Novel compoundSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 2846US2004034066A1Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]thiazolidine-2,4-dioneFiled 2001·Application pending·0 cites
- 2941US2006094691A1Inclusion complexes of rosiglitazoneCRAIG ANDREW S·Filed 2003·Application pending·0 cites
- 3038US2007167494A1Process for preparing a polymorph or rosiglitazone maleateGLAXO GROUP LTD·Filed 2004·Application pending·0 cites
- 3137US2004102485A1Tartrate salt of thiazolidinedione derivativeFiled 2001·Application pending·0 cites
- 3236US2001008940A1Novel processSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 3336US2004044043A1Thiazolidinedione derivative and its use as antidiabeticFiled 2001·Application pending·0 cites
- 3436US2004082620A15'-4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate saltFiled 2001·Application pending·0 cites
- 3534US2006083784A1Amorphous pharmaceutical compositionsSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 3630US6346371B1Photographic element containing a DIR couplerEASTMAN KODAK CO·Filed 1999·Granted Feb 12, 2002·0 cites·14 claims
- 3730US2004024027A15(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceuticalFiled 2001·Application pending·0 cites
- 3828US2004087629A1Tartrate salts of thiazolidinedione derivativeFiled 2001·Application pending·0 cites
- 3927US2004014790A1Tartrate salt of thiazolidinedione derivativeFiled 2001·Application pending·0 cites
- 4026US2004014791A1Thiazolidinedione derivative and its use as antidiabeticFiled 2001·Application pending·0 cites
- 4126US2004029926A1Thiazolidinone nitrate saltFiled 2001·Application pending·0 cites
- 4226US2004048899A1Tartrate salts of thiazollidnedione derivativeFiled 2001·Application pending·0 cites
- 4325US2003162815A1Thiazolidinedione salt for treatment of diabetes mellitusFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Craig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →